The Inhibition of Inflammatory Signaling Pathway by Secretory Leukocyte Protease Inhibitor can Improve Spinal Cord Injury
- PMID: 31993863
- PMCID: PMC11448923
- DOI: 10.1007/s10571-020-00799-1
The Inhibition of Inflammatory Signaling Pathway by Secretory Leukocyte Protease Inhibitor can Improve Spinal Cord Injury
Abstract
Spinal cord injury leads to loss of sensory motor functions below the damaged area, and can significantly affects physical and mental health. An effective spinal cord injury treatment is currently unavailable, in part, because of the intricacy of the brain, as well as the complex pathophysiological mechanism of the injury. Inflammation is an important biological process in multitudinous diseases, with no exception for spinal cord injury. Nuclear factor kappa beta (NF-κB) signaling pathway is a key inflammatory element, as it is involved in cell survival, apoptosis, proliferation, differentiation, and immune response. Activation of the NF-κB signaling pathway leads to the release of a large number of inflammatory factors that can affect tissue repair. Hence, the inhibition of inflammatory responses could improve the repair of injured spinal cord tissues. Secretory leukocyte protease inhibitor (SLPI) has anti-inflammatory and anti-bacterial properties, and promotes wound healing. SLPI can bind to the promoter region of tumor necrosis factor-αand interleukin-8 (IL-8) to inhibit the NF-κB signaling pathway. Additionally, SLPI can reduce secondary damages after spinal cord injury, and prevent further complications. In this report, we analyze the pathophysiological mechanism of spinal cord injury, the role of NF-κB signaling pathway following spinal cord injury, and how SLPI regulates the NF-κB signaling pathway to curtail inflammatory reaction.
Keywords: Ecretory leukocyte protease inhibitor; Inflammation; Nuclear factor kappa beta signaling pathway; Oxidative stress; Spinal cord injury.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures

Similar articles
-
Geniposide exerts protective effects on spinal cord injury in rats by inhibiting the IKKs/NF-κB signaling pathway.Int Immunopharmacol. 2021 Nov;100:108158. doi: 10.1016/j.intimp.2021.108158. Epub 2021 Sep 20. Int Immunopharmacol. 2021. PMID: 34555642
-
ACY1215 Exerts Anti-inflammatory Effects by Inhibition of NF-κB and STAT3 Signaling Pathway to Repair Spinal Cord Injury.Biol Pharm Bull. 2024;47(10):1734-1745. doi: 10.1248/bpb.b23-00603. Biol Pharm Bull. 2024. PMID: 39477466
-
Curcumin modulates TLR4/NF-κB inflammatory signaling pathway following traumatic spinal cord injury in rats.J Spinal Cord Med. 2015 Mar;38(2):199-206. doi: 10.1179/2045772313Y.0000000179. Epub 2014 Jan 3. J Spinal Cord Med. 2015. PMID: 24621048 Free PMC article.
-
The NF-κB Pathway: a Focus on Inflammatory Responses in Spinal Cord Injury.Mol Neurobiol. 2023 Sep;60(9):5292-5308. doi: 10.1007/s12035-023-03411-x. Epub 2023 Jun 7. Mol Neurobiol. 2023. PMID: 37286724 Review.
-
OTULIN Can Improve Spinal Cord Injury by the NF-κB and Wnt/β-Catenin Signaling Pathways.Mol Neurobiol. 2024 Nov;61(11):8820-8830. doi: 10.1007/s12035-024-04134-3. Epub 2024 Apr 2. Mol Neurobiol. 2024. PMID: 38561559 Review.
Cited by
-
Bone mesenchymal stem cell-derived extracellular vesicles deliver microRNA-23b to alleviate spinal cord injury by targeting toll-like receptor TLR4 and inhibiting NF-κB pathway activation.Bioengineered. 2021 Dec;12(1):8157-8172. doi: 10.1080/21655979.2021.1977562. Bioengineered. 2021. PMID: 34663169 Free PMC article.
-
Neuroprotective treatment with the nitrone compound OKN-007 mitigates age-related muscle weakness in aging mice.Geroscience. 2024 Oct;46(5):4263-4273. doi: 10.1007/s11357-024-01134-y. Epub 2024 Mar 21. Geroscience. 2024. PMID: 38512579 Free PMC article.
-
Low-dose lipopolysaccharide inhibits spinal cord injury-induced neuronal apoptosis by regulating autophagy through the lncRNA MALAT1/Nrf2 axis.PeerJ. 2023 Aug 28;11:e15919. doi: 10.7717/peerj.15919. eCollection 2023. PeerJ. 2023. PMID: 37663283 Free PMC article.
-
Daphnoretin inhibited SCI-induced inflammation and activation of NF-κB pathway in spinal dorsal horn.Aging (Albany NY). 2024 Jun 5;16(11):9680-9691. doi: 10.18632/aging.205893. Epub 2024 Jun 5. Aging (Albany NY). 2024. PMID: 38843384 Free PMC article.
-
Mucuna laticifera: unprecedented L-dopa content and its role in neurodegenerative and inflammatory conditions.3 Biotech. 2024 May;14(5):126. doi: 10.1007/s13205-024-03969-w. Epub 2024 Apr 4. 3 Biotech. 2024. PMID: 38585411 Free PMC article.
References
-
- Allison DJ, Ditor DS (2015) Immune dysfunction and chronic inflammation following spinal cord injury. Spinal Cord 53:14–18 - PubMed
-
- Ambrosi N, Caro F, Guerrieri D et al (2018) SLPI expression on kidney biopsies correlates with better clinical outcomes. Transplantation 102:S326–S327
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical